It's quite common for successful stage 2 trials to trigger an acquisition of the technology. It's not necessary to go all the way to stage 3 to elicit value.
https://biopharmadealmakers.nature....ds-in-pharmaceutical-mergers-and-acquisitions
Market Cap still only $60m - should be $180m!, page-54
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.002(3.70%) |
Mkt cap ! $385.8M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.2¢ | $52.15K | 987.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 3526594 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 661910 | 26 |
View Market Depth
| Last trade - 11.56am 22/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |